For the past 4 years, the Mailman School of Public Health of Columbia University has had an NCI-funded R25T Training Program for cancer investigators in Population Sciences. Like our longstanding T32 program, the R25 program is a collaboration of faculty in three departments: Epidemiology, Biostatistics, and Environmental Health Sciences. Increasingly, investigators in cancer-related population sciences require not only expertise in their own specific disciplines but a broad-based multidisciplinary perspective, including a more than superficial understanding of molecular genetics, clinical oncology, toxicology, health services and health outcomes research, and behavioral sciences. The R25 provides 6 trainees (3 pre- and 3 postdoctoral) annually with cross-disciplinary education in cancer prevention and control, an in-depth research experience, and access to a large faculty in the population sciences with numerous funded research projects in cancer. Graduates of the program have gone on to prestigious academic and research positions. In this competing renewal, we propose to extend our program by providing more training in clinical cancer genetics, health economics, and the basic biology of cancer. In addition to required and recommended courses within the School of Public Health, our program offers an innovative specialized curriculum, with 2-month individualized modules in year 2 giving trainees hands-on experience in: data collection and interviewing in a clinical setting;behavioral research;laboratory research;health services and outcomes;clinical oncology, and data analysis. Each trainee is required to take courses in pathology, research ethics, and research funding;to undertake an in-depth multidisciplinary project with a focus in his/her specialty;and to make two presentations/year at a multidisciplinary weekly conference. Trainees have the opportunity to attend cancer meetings and meetings in their discipline and are encouraged but not required to make presentations at those meetings. Postdoctoral trainees are required to submit research grant proposals for mock peer review by the faculty. For this specialized program, we propose to reduce our trainees from 6 (3 pre-, 3 postdoctoral) to 5 (1 pre-, 4 postdoctoral);to add a Program Coordinator for day-to- day operations;to implement a more detailed evaluation plan;and to add to our Advisory Committee, which oversees recruitment, performance and evaluation of the trainees, an external advisory committee of three outstanding scientist/educators. Our R25 Training Program utilizes the rich research environment of the Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital, Harlem Hospital, the Washington Heights/Harlem communities, and New York City.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA094061-10
Application #
8142798
Study Section
Subcommittee G - Education (NCI)
Program Officer
Perkins, Susan N
Project Start
2002-07-01
Project End
2012-08-31
Budget Start
2011-08-01
Budget End
2012-08-31
Support Year
10
Fiscal Year
2011
Total Cost
$493,948
Indirect Cost
Name
Columbia University (N.Y.)
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Kahn, Justine M; Athale, Uma H; Clavell, Luis A et al. (2017) How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic. J Pediatr Health Care 31:e1-e6
Kahn, Justine M; Ozuah, Nmazuo W; Dunleavy, Kieron et al. (2017) Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes. Blood Adv 1:1945-1958
Accordino, Melissa K; Hershman, Dawn L (2016) Reply to F. Dayyani et al. J Oncol Pract 12:277
White, Alexandra J; Bradshaw, Patrick T; Herring, Amy H et al. (2016) Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environ Int 89-90:185-92
Wright, Jason D; Huang, Yongmei; Burke, William M et al. (2016) Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer. Obstet Gynecol 127:109-18
Accordino, Melissa K; Wright, Jason D; Vasan, Sowmya et al. (2016) Serum Tumor Marker Use in Patients With Advanced Solid Tumors. J Oncol Pract 12:65-6, e36-43
Al Mulla, Naima; Kahn, Justine M; Jin, Zhezhen et al. (2016) Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes. Biol Blood Marrow Transplant 22:1525-1530
Chatterjee, Sudeshna; Chen, Ling; Tergas, Ana I et al. (2016) Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer. Obstet Gynecol 127:992-1002
George, E M; Burke, W M; Hou, J Y et al. (2016) Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynaecological surgery. BJOG 123:455-61
Kolb, Michelle; Offer, Katharine; Jin, Zhezhen et al. (2016) Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 22:957-61

Showing the most recent 10 out of 99 publications